NCT06513949 - Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

December 31, 2027

Conditions

Acute Respiratory Distress SyndromeAdult Respiratory Distress SyndromeAcute Lung InjuryAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)

Interventions

BIOLOGICAL

Atibuclimab

monoclonal antibody against human CD14

OTHER

Placebo

Sterile normal saline for injection

Trial Locations (2)

RECRUITING

Harborview Medical Center, Seattle

RECRUITING

University of Washington, Seattle